Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin 0.3% Plus Fluocinolone Acetonide 0.025% Otic Solution in Acute Otitis Externa
NCT04636957Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jan 2021
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of fluocinolone in acute otitis externa (AOE) (2 arms), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Clinical Cure. Started Jan 2021; status: completed.
02
Drugs
fluocinolone
03
Conditions
acute otitis externa (AOE)
Beyond the preview
Go deeper on NCT04636957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04636957.